Mathieu Chevrier

Stock Analyst at Citigroup

(2.70)
# 2,094
Out of 5,012 analysts
2
Total ratings
100%
Success rate
21.01%
Average return
Main Sectors:

Stocks Rated by Mathieu Chevrier

ResMed
Mar 5, 2025
Upgrades: Buy
Price Target: n/a
Current: $283.28
Upside: -